biodistribution
Showing 1 - 25 of 638
Diagnostic Agent Adverse Reaction, Radiation Exposure Trial in New Haven (18F-LY3950321, PET Scan)
Recruiting
- Diagnostic Agent Adverse Reaction
- Radiation Exposure
- 18F-LY3950321
- PET Scan
-
New Haven, ConnecticutInvicro, LLC
Mar 20, 2023
Pretomanid in Tuberculosis Patients Using 18F-Pretomanid PET
Recruiting
- Tuberculosis
- 18F-Pretomanid PET/CT
-
Baltimore, MarylandJohns Hopkins Medical Institutions
Jan 30, 2023
18F-Fluorodeoxysorbitol (18F-FDS) in Diseased Patients
Recruiting
- Enterobacterial Infections
- +3 more
- 18F-FDS PET/CT
-
Baltimore, MarylandJohns Hopkins Medical Institutions
Jan 31, 2023
11C-para-aminobenzoic Acid
Recruiting
- Renal Excretion
- +3 more
- 11C-para-aminobenzoic acid PET/CT
- Probenecid
-
Baltimore, MarylandJohns Hopkins Medical Institutions
Jan 30, 2023
Suspected Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Trial in Philadelphia ([18F]FluorThanatrace, PET/CT
Recruiting
- Suspected Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- [18F]FluorThanatrace
- PET/CT imaging sessions
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Nov 7, 2022
Mild Cognitive Impairment Trial in Winston-Salem ([11C]Acetoacetate[18F]Fluorodeoxyglucose positron emission tomography scan)
Enrolling by invitation
- Mild Cognitive Impairment
- [11C]Acetoacetate[18F]Fluorodeoxyglucose positron emission tomography scan
-
Winston-Salem, North CarolinaWake Forest School of Medicine
Dec 22, 2022
Alzheimer Trial in Beijing (XTR006)
Recruiting
- Alzheimer Disease
- XTR006
-
Beijing, Beijing Shi, ChinaChinese PLA General Hospital
Nov 21, 2023
Metastatic Prostate Cancer Trial in Perth (64Cu-DOTA-TLX592)
Recruiting
- Metastatic Prostate Cancer
-
Perth, Western Australia, Australia
- +1 more
Nov 25, 2022
Endocrine Neoplasia Trial in Houston (4-[18F]Fluoro-1-Naphthol)
Recruiting
- Endocrine Neoplasia
-
Houston, TexasMD Anderson Cancer Center
Nov 16, 2022
Biodistribution of [11C]PIB in Risk Factors for Alzheimer's
Enrolling by invitation
- Alzheimer Disease
- Mild Cognitive Impairment
-
Winston-Salem, North CarolinaWake Forest Baptist Medical Center
Apr 29, 2022
Healthy Subjects (HS) Trial in Huangpu (DaTSCAN™ Ioflupane (123I) Injection)
Completed
- Healthy Subjects (HS)
- DaTSCAN™ Ioflupane (123I) Injection
-
Huangpu, Shanghai, ChinaRujin hospital, affiliated to Shanghai Jiaotong University, Scho
Jun 20, 2022
Neuropathic Pain Trial in Saint Louis (Ondansetron 8mg with Saline & Tariquidar, Ondansetron 16mg with Saline & Tariquidar)
Terminated
- Neuropathic Pain
- Ondansetron 8mg with Saline & Tariquidar
- Ondansetron 16mg with Saline & Tariquidar
-
Saint Louis, MissouriWashington University in St. Louis
Mar 28, 2022
Prostate Cancer, Bone Metastases Trial in Philadelphia ([68Ga]P15-041)
Recruiting
- Prostate Cancer
- Bone Metastases
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Apr 29, 2022
Amyloidosis; Systemic Trial in Knoxville (124I-AT03)
Recruiting
- Amyloidosis; Systemic
-
Knoxville, TennesseeUniversity of Tennessee Medical Center
Mar 14, 2022
Tauopathies Trial in Philadelphia (drug, diagnostic test, behavioral)
Active, not recruiting
- Tauopathies
- 11C-HY-2-15 PET
- +3 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Sep 6, 2023
Bacterial Infections Trial in Philadelphia (11C-Trimethoprim)
Recruiting
- Bacterial Infections
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Jan 28, 2022
Healthy Volunteers Trial run by the NIDDK (Vitamin C)
Completed
- Healthy Volunteers
- Vitamin C
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 24, 2023
Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial (AAA617, 68Ga-PSMA-11)
Not yet recruiting
- Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- (no location specified)
Aug 16, 2023
Advanced and/or Metastatic Solid Tumours Trial in Groningen (Radiolabelled CB307, CB307)
Recruiting
- Advanced and/or Metastatic Solid Tumours
- Radiolabelled CB307
- CB307
-
Groningen, NetherlandsUniversity Medical Center Groningen,
Apr 28, 2023
Amyotrophic Lateral Sclerosis (ALS) Trial in Stanford (18F-OP-801)
Not yet recruiting
- Amyotrophic Lateral Sclerosis (ALS)
-
Stanford, CaliforniaStanford University
May 25, 2022
Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Los Angeles (99mTc-based PSMA Imaging and Surgery Agent, Computed
Recruiting
- Prostate Carcinoma
- Recurrent Prostate Carcinoma
- 99mTc-based PSMA Imaging and Surgery Agent
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Jul 21, 2022